NG2 glia regulate brain innate immunity via TGF-β2/TGFBR2 axis

Area of Science:

• Neuroimmunology
• Cell Biology
• Neuroscience

Background:

• Brain innate immunity is crucial for normal function, and its imbalance contributes to neurological diseases like Parkinson's disease (PD).
• The precise mechanisms regulating brain innate immunity and their role in PD pathogenesis remain largely unknown.

Purpose of the Study:

• To investigate the impact of neuron-glial antigen 2 (NG2) glia on brain innate immunity.
• To elucidate the molecular mechanisms by which NG2 glia modulate neuroinflammation and their relevance in Parkinson's disease models.

Main Methods:

• Utilized Cre-inducible diphtheria toxin receptor (iDTR) system for NG2 glia ablation in mice.
• Performed RNA sequencing on mouse brains with ablated NG2 glia and lipopolysaccharide (LPS) challenge.
• Employed 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model to assess neuroinflammation and dopaminergic neuron survival.

Main Results:

• NG2 glia maintain brain immune homeostasis via TGF-β2/TGFBR2/CX3CR1 signaling, suppressing microglia activation.
• Ablation of NG2 glia led to reduced microglia signature gene expression and heightened inflammatory responses to LPS.
• NG2 glia deficiency exacerbated neuroinflammation and dopaminergic neuron loss in an MPTP-induced Parkinson's disease model.

Conclusions:

• NG2 glia are critical regulators of brain innate immunity and neuroinflammation.
• Targeting NG2 glia offers a potential therapeutic strategy for neurological disorders, including Parkinson's disease.